Project description
New methodology for pharmaceutical wastewater treatment
Pharmaceuticals represent a major contributor to water contamination. Iodinated X-ray contrast medium agents (CMA) are used for the imaging of soft tissues in elevated doses for each imaging operation. CMAs are resistant to conventional biological wastewater treatment and have been detected at high concentrations not only in the effluents of wastewater treatment plants but in drinking water as well. The EU-funded REMEDI project will train early-stage researchers and future professionals in the domain of competitive use of water resources within an industrial environment, focussing on water scarcity provoked by pharmaceutical contamination. The project is a joint effort between the environmental company Tauw GmbH, the Polytechnic University of Milan and the University of Warwick.
Fields of science
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs
- engineering and technologyenvironmental engineeringwater treatment processesdrinking water treatment processes
- engineering and technologyenvironmental engineeringwater treatment processeswastewater treatment processes
- natural sciencesearth and related environmental scienceshydrology
Programme(s)
Call for proposal
H2020-MSCA-ITN-2020
See other projects for this call
Funding Scheme
MSCA-ITN-EID - European Industrial DoctoratesCoordinator
20133 Milano
Italy
Participants (2)
47441 Moers
CV4 8UW Coventry